No evidence of RALGDS mutations in cutaneous melanoma.

No evidence of RALGDS mutations in cutaneous melanoma. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

No evidence of RALGDS mutations in cutaneous melanoma. Abstract Text:

Katarina Omholt,Johan Hansson,Katarina Omholt,Johan Hansson,Katarina Omholt,Johan Hansson,

No evidence of RALGDS mutations in cutaneous melanoma. Publishing Authors By Initials

K Omholt,J Hansson,K Omholt,J Hansson,K Omholt,J Hansson,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

No evidence of RALGDS mutations in cutaneous melanoma. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Melanoma research

VOLUME: 17

Page Numbers: 410-2

Journal Abbreviation:

ISSN: 0960-8931

DAY: 9

MONTH: Dec

YEAR: 2007

No evidence of RALGDS mutations in cutaneous melanoma. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9109623

No evidence of RALGDS mutations in cutaneous melanoma. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: No evidence of RALGDS mutations in cutaneous melanoma. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for No evidence of RALGDS mutations in cutaneous melanoma.

AFFILIATION: Department of Oncology-Pathology, Karolinska Institutet, Cancer Center Karolinska, Karolinska University Hospital Solna, Stockholm, Sweden.

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Melanoma Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

No evidence of RALGDS mutations in cutaneous melanoma Related Publications

• A new method for isolating physiologically active Mg-protoporphyrin monomethyl ester, the substrate of the cyclase enzyme of the chlorophyll biosynthetic pathway.
• An autocatalytic cleavage in the C terminus of the human MUC2 mucin occurs at the low pH of the late secretory pathway.
• Chemical changes in rubber allergens during vulcanization.
• Comparing two microarray platforms for identifying mutated genes in barley (Hordeum vulgare L.).
• Deglycosylation by gaseous hydrogen fluoride of mucus glycoproteins immobilized on nylon membranes and in microtiter wells.
• Dimerization of the human MUC2 mucin in the endoplasmic reticulum is followed by a N-glycosylation-dependent transfer of the mono- and dimers to the Golgi apparatus.
• Effect of salt and surfactant concentration on the structure of polyacrylate gel/surfactant complexes.
• Entamoeba histolytica cysteine proteases cleave the MUC2 mucin in its C-terminal domain and dissolve the protective colonic mucus gel.
• Experimental and clinical studies in aetiologic role of bile reflux in acute pancreatitis.
• Flies' lives on a crab.
• For the safety and benefit of current and future patients.
• Functional classification and central nervous projections of olfactory receptor neurons housed in antennal trichoid sensilla of female yellow fever mosquitoes, Aedes aegypti.
• Human MUC5AC mucin dimerizes in the rough endoplasmic reticulum, similarly to the MUC2 mucin.
• Identification of transient glycosylation alterations of sialylated mucin oligosaccharides during infection by the rat intestinal parasite Nippostrongylus brasiliensis.
• Innate immunity, macrophage activation, and atherosclerosis.
• Internal repeat variability in mucin sequences.
• Molecular characterization of the large heavily glycosylated domain glycopeptide from the rat small intestinal Muc2 mucin.
• No evidence of RALGDS mutations in cutaneous melanoma.
• O-glycosylated MUC2 monomer and dimer from LS 174T cells are water-soluble, whereas larger MUC2 species formed early during biosynthesis are insoluble and contain nonreducible intermolecular bonds.
• PBSC harvests individually optimized by using pre-collection CD34(+) values and on-line flow cytometric analysis of the mononuclear cell enrichment.
• Plasma membrane and vesicular monoamine transporters in normal endometrium and early pregnancy decidua.
• Purification and characterization of sialyl-Le(a)-carrying mucins of human bile; evidence for the presence of MUC1 and MUC3 apoproteins.
• Sensitivity after bilateral prophylactic mastectomy and immediate reconstruction.
• The N terminus of the MUC2 mucin forms trimers that are held together within a trypsin-resistant core fragment.
• The glycosylation of rat intestinal Muc2 mucin varies between rat strains and the small and large intestine. A study of O-linked oligosaccharides by a mass spectrometric approach.
• The human MUC2 mucin apoprotein appears to dimerize before O-glycosylation and shares epitopes with the 'insoluble' mucin of rat small intestine.
• The recombinant C-terminus of the human MUC2 mucin forms dimers in Chinese-hamster ovary cells and heterodimers with full-length MUC2 in LS 174T cells.
• The salivary mucin MG1 (MUC5B) carries a repertoire of unique oligosaccharides that is large and diverse.
• The transcripts of the apomucin genes MUC2, MUC4, and MUC5AC are large and appear as distinct bands.
• Uncomplicated duplex kidney and DMSA scintigraphy in children with urinary tract infection.